Clinical Trial Update: Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumonia.

View source ↗

Summary

A clinical trial is evaluating different methods of inhaled aerosolized polymyxin B to treat pneumonia caused by carbapenem-resistant gram-negative bacteria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Pneumonia
• Carbapenem-resistant Enterobacteriaceae Infection

Drugs mentioned

• POLYMYXIN B (POLYMYXIN B SULFATE)

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Carbapenem-Resistant Enterobacteriaceae Infection, Pneumonia - Bacterial | Status: RECRUITING